functional ingredients for glp-1 Nutritional priorities to support therapy obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society UMZU Sensolin GLP-1 Support Supplement,

doi: 10.1159/000485820

GLP-1 Medications with a simple generic name of "semaglutide", "liraglutide", "tirzepatide", "dulaglutide", "exenatide", "exenatide microspheres", or "insulin degludec/liraglutide" and at least one of: A pharmaceutical class of "ANTI-OBESITY GLUCAGON-LIKE PEPTIDE-1 RECEP AGONIST" or "ANTIHYPERGLYCEMIC - INCRETIN MIMETICS COMBINATION" A pharmaceutical class that contains "GLP-1" A pharmaceutical subclass that contains the text "GLP-1"

They are: Clinically proven to help individuals lose up to 25% of body weight in one year

Marketed as Mounjaro for the treatment of type 2 diabetes, the drug was subsequently approved as Zepbound for obesity by the FDA in November 2023

Photoaffinity, NMR, and molecular modeling